CAMP4 Therapeutics Sets IPO Price at $11 per Share for 6.82 Million Shares

CAMP4 Therapeutics Corporation (“CAMP4”) has announced the pricing of its initial public offering (IPO) consisting of 6,820,000 shares of common stock at a price of $11.00 per share. All shares are being offered by CAMP4. The gross proceeds from this offering, before deducting underwriting discounts, commissions, and other expenses, are anticipated to be around $75.0 million. Trading of CAMP4’s common stock is expected to commence on the Nasdaq Global Market on October 11, 2024, under the ticker symbol “CAMP.” The offering is projected to close on October 15, 2024, pending the fulfillment of customary closing conditions. Additionally, CAMP4 has granted the underwriters a 30-day option to purchase up to an extra 1,023,000 shares of common stock at the offering price, minus any underwriting discounts and commissions.

J.P. Morgan, Leerink Partners, Piper Sandler, and William Blair are serving as joint book-running managers for the IPO.

A registration statement for the shares being sold has been filed with the U.S. Securities and Exchange Commission (SEC) and became effective on October 10, 2024. The offering will be conducted solely through a prospectus.

This